The Nitinol Stone Extraction System market is dominated by North America, which holds a 40% value in the global market, driven by advanced healthcare infrastructure, high adoption rates of minimally invasive procedures, and robust R&D investments. Europe follows with a 25% value, supported by aging demographics, stringent regulatory frameworks ensuring device quality, and strong reimbursement policies. The Asia Pacific region is the fastest-growing segment, with a 20% value, fueled by rising healthcare investments, urbanization, and expanding urology care networks in countries like India and China. Latin America and the Middle East & Africa collectively account for 15% and 5%, respectively, with growth tied to improving healthcare access and partnerships with global manufacturers.